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ABSTRACT
Bone marrow-derived progenitor cells are mobilized into the peripheral blood after acute myocardial injury and in chronic ischemic heart disease. However, the mechanisms responsible for this
mobilization are poorly understood. We examined the relationship between plasma levels of bioactive lipids and number of circulating progenitor cells (CPCs) in patients (N = 437) undergoing
elective or emergent cardiac catheterization. Plasma levels of sphingosine-1 phosphate (S1P)
and ceramide-1 phosphate (C1P) were quantified using mass spectrometry. CPCs were assessed
using flow cytometry. S1P levels correlated with the numbers of CD341, CD341/CD1331, and
CD341/CXCR41 CPCs even after adjustment for potential confounding factors. However, no significant correlation was observed between C1P levels and CPC count. Plasma levels of S1P correlated with the number of CPCs in patients with coronary artery disease, suggesting an important
mechanistic role for S1P in stem cell mobilization. The therapeutic effects of adjunctive S1P therapy to mobilize endogenous stem cells need to be investigated. STEM CELLS TRANSLATIONAL
MEDICINE 2017;6:731–735
2016;5:1–5

SIGNIFICANCE
IGNIFICANCESTATEMENT
Bone marrow-derived progenitor cells are mobilized after acute myocardial injury and in chronic
ischemic heart disease. However, the mechanisms responsible for this mobilization are poorly
understood. The relationship between plasma levels of the bioactive lipid sphingosine-1
phosphate (S1P) and circulating progenitor cells was examined in 437 patients undergoing
elective or emergent cardiac catheterization. S1P levels correlated with the numbers of
CD341, CD341/CD1331, and CD341/CXCR41 cells, even after adjustment for potential
confounding factors. These data suggest an important mechanistic role for S1P in stem cell
mobilization that can be explored therapeutically as an adjunctive in future cardiac regenerative studies.

INTRODUCTION
Circulating progenitor cells (CPCs) are mononuclear cells that originate primarily from the bone
marrow, differentiate into hematopoietic and
endothelial cells, and contribute to vascular
repair and cardiomyocyte regeneration [1–5].
We and others have shown that low CPC counts
are predictors of adverse cardiovascular events
and are likely biomarkers of regenerative potential [6, 7]. Studies using CPC mobilization as a
method to enhance cardiac recovery in heart
failure or after myocardial infarction have
achieved modest success, probably because of
incomplete understanding of the mechanisms
underlying mobilization and homing of regenerative cells.

Several chemokines, including vascular endothelial growth factor (VEGF) and stromal cell
derived factor-1 (SDF-1), play an important role
in the recruitment of CPCs from the bone marrow [8, 9]. However, the exclusive role of these
chemokines has been debated [10]. After acute
myocardial infarction (AMI), matrix metalloproteinases (MMPs) and proteases are upregulated
in the myocardium [11], leading to the degradation of several chemokines [12]. More recently,
bioactive lipids, notably sphingosine-1 phosphate (S1P), that are resistant to MMPs have
been characterized as chemoattractants that
enhance mobilization and homing of stem
cells from the bone marrow [13, 14]. Raising
plasma S1P levels in a mouse model of AMI

STEM CELLS TRANSLATIONAL MEDICINE 2017;6:731–735
www.StemCellsTM.com
2016;5:1–5 www.StemCellsTM.com

c 2016 Press
The Authors
O
©AlphaMed
2016
STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press

ID: srinivasanv Time: 17:29 I Path: //chenas03/Cenpro/ApplicationFiles/Journals/Wiley/SCTM/Vol00603/170049/Comp/APPFile/JW-SCTM170049

S1P and
and Stem
Stem Cell
Cell Mobilization
Mobilization in CAD
S1P

2732

increased CPC mobilization and enhanced cardiac recovery
[15]. Whether an association between bioactive lipids and
CPC counts in patients with coronary artery disease (CAD)
exists is unclear and is the subject of this study. We
hypothesized that bioactive lipids would mobilize CPCs
and thus their levels will be associated with higher counts
of CPCs.

Table 1. Demographics and clinical characteristics
Dataa (N = 437)

Characteristic

Age, median, yr (SD)

64 (13)

Male sex, n (%)

282 (65)

Black race, median (SD)

102 (23)
2

Body mass index, median, kg/m (SD)

29 (6)

Clinical characteristics
Systolic blood pressure, mmHg

MATERIALS AND METHODS

Diastolic blood pressure, mmHg

137 (21)
70 (22)

Study Design

Hypertension, n (%)

197 (45)

We examined the relationship between bioactive lipids and
CPCs in subjects (N = 437) recruited into the Emory Cardiovascular Biobank, a prospective cohort consisting of patients
aged 20 to 90 years who were undergoing elective or emergent cardiac catheterization. Subjects with congenital heart
disease, severe valvular heart disease, severe anemia, recent
blood transfusion, myocarditis, active inflammatory diseases,
and cancer were excluded. Obstructive CAD was defined
as .50% luminal narrowing in a major epicardial vessel.
The study was approved by the institutional review board
at Emory University. All subjects provided written informed
consent.

Hyperlipidemia, n (%)

174 (40)

Diabetes mellitus, n (%)

160 (37)

Obstructive coronary artery disease, n (%)

247 (57)

Previous myocardial infarction, n (%)

114 (26)

Heart failure, n (%)

125 (29)

Ejection fraction, n (%)

53 (13)

LDL, median (SD), mg/dl

93 (42)

HDL, median (SD), mg/dl

42 (15)

Creatinine, median (IQR), mg/dl

1.0 (0.89–1.3)

Bioactive lipids, median (IQR)
Sphingosine-1 phosphate, mM
Ceramide-1 phosphate, mM

Quantitation of Bioactive Lipids
Arterial blood was collected in EDTA tubes and plasma was isolated by centrifuging whole blood for 10 minutes at 800g. Lipids
were extracted from plasma using acidified organic solvents, as
previously described [16].

Measurement of Circulating Progenitor Cells Counts
Peripheral blood mononuclear cells were incubated with
fluorochrome-labeled monoclonal anti-human mouse antibodies within 4 hours of blood draw. Cell populations enriched for CPCs were quantified using flow cytometry as
CD45 dim cells coexpressing CD34, CD133, vascular endothelial growth factor receptor 2 (VEGFR2), or CXCR4, and their
combination, as previously described [6]. The CD45 dim population consists of CD341 cells with dim expression of
CD45, thus excluding hematopoietic CD341/CD45 med and
CD341/CD45 hi hematogones or bone marrow-derived early
B-cell precursors. Flow data were analyzed with FlowJo software (Ashland, OR, http://www.flowjo.com). CPC populations are reported as absolute counts (cells per ml of whole
blood), determined using Accucheck Counting Beads (Thermo
Fisher Scientific Life Sciences, Waltham, MA, http://www.
thermofisher.com).

Statistical Analysis
Subject characteristics were reported as descriptive statistics with means, medians, standard deviations, and ranges,
where appropriate. Correlation analyses were performed
using the Pearson’s correlation for normally distributed variables and Spearman’s correlation for non-normally distributed variables. Cell counts were non-normally distributed
and were transformed (natural log[cell count11]) before
parametric analyses. Multivariable analyses using linear regression of log-transformed outcomes variables adjusted for
age, sex, race (black vs. other), and body mass index, as well

0.84 (0.64–1.0)
40 (18–85)

Circulating progenitor cells, median (IQR)
CD341, cells/ml

1.82 (1.16–2.75)

CD341/CD1331, cells/ml

0.77 (0.45–1.20)

CD341/CXCR41, cells/ml

1.01 (0.65–1.54)

CD341/VEGFR21, cells/ml

0.18 (0.10–0.34)

Categorical data are provided as n (%). Continuous variables are given
as mean (SD) or median (interquartile range) where noted.
Abbreviations: HDL, high-density lipoprotein; IQR, interquartile range;
LDL, low-density lipoprotein.

a

variables with a p value , .1 on univariable analysis. Analyses
were performed using IBM SPSS Statistics version 21 (IBM,
Armonk, NY, https://www.ibm.com).

RESULTS
The majority of enrolled patients were white men; the median age
of the patients was 64 years. They had multiple CAD risk factors
and 57% had obstructive CAD (Table 1).
On univariable analyses, plasma S1P and C1P levels were
negatively correlated with male sex, history of myocardial infarction, hypertension, hyperlipidemia, and serum creatinine
level, whereas they positively correlated with high-density
and low-density lipoprotein levels. Previous myocardial infarction did not correlate with total C1P levels and was not included
in the model. After multivariable adjustments, only the creatinine level and hyperlipidemia remained independently associated with S1P levels (Table 2).
The number of CPCs (CD45 dim cells), in particular CD341
(r = .187; p , .001), CD341/CD1331 (r = .217; p , .001), and
CD341/CXCR41 (r = .207; p , .001) cells correlated positively
with S1P levels. However, CD341/VEGFR21 cells did not significantly correlate with S1P levels (r = 20.30; p = .531), and
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Table 2. Independent predictors of bioactive lipidsa
Variables

Sphingosine-1 phosphateb b coefficient
(p value)

Total Ceramide-1 phosphateb b coefficient
(p value)

20.01 (.218)

5.68 (.317)

0.00 (.866)

2119.51 (.448)

Black race

0.00 (.812)

2253.31 (.358)

Body mass index, per kg/m2

0.02 (.204)

27.19 (.037)

Age, per year
Male sex

Clinical characteristics
Hypertension

20.67 (.112)

2400.53 (.049)

Hyperlipidemia

20.54 (.012)

2331.15 (.110)

Previous myocardial infarction

20.78 (.191)

N/A

Low-density lipoprotein, per unit

0.00 (.323)

0.558 (763)

High-density lipoprotein, per unit

0.01 (.095)

22.92 (.570)

20.30 (.045)

298.44 (.535)

Creatinine, per unit
Circulating progenitor cells

24.29 (.947)

CD341, per unit

0.29 (<.001)

CD341/CD1331, per unit

0.55 (<.001)

26.08 (.833)

CD341/CXCR41, per unit

0.56 (<.001)

148.03 (.192)

CD341/VEGFR21, per unit

0.16 (.687)

80.63 (.828)

Variables with p , .1 on univariable analyses were included in the multivariable regression model in addition to age, body mass index, sex, and race for
each cell type. Mean arterial pressure, diabetes mellitus, heart failure, and ejection fraction were not correlated with bioactive lipids.
b
Data in bold type are statistically significant at p , .05.
Abbreviation: N/A, not applicable.
a

CPC counts did not correlate with C1P levels. On multivariable
analysis, S1P levels were significantly associated with the
aforementioned CPC populations (Fig. 1; Table 2).

DISCUSSION
The role of bone marrow-derived progenitor cells in cardiac
repair is still being studied in randomized trials; however,
strong evidence suggests that CPCs are mobilized after cardiac injury [17, 18]. In the largest cohort to date examining
the relationship between plasma bioactive lipids and circulating stem cells, we demonstrated a strong correlation between
plasma S1P levels and the number of CPCs in patients with
CAD.
We and others showed that the degree of CPC mobilization correlates with functional cardiac recovery [19] and
clinical outcomes [6, 20]. Ischemic myocardial injury activates the immune system, including the complement cascade [21], which plays an important role in the release of
bioactive lipids such as S1P from blood [22] and endothelial
cells [23], thus increasing S1P’s transendothelial gradient
[14]. Of note, number of CD341/VEGFR21 cells did not correlate with plasma S1P levels. This could be intrinsic to this
cell population, which could be more responsive to VEGF. Interestingly, in an animal model of AMI, temporary elevation
of S1P in the plasma resulted in enhanced bone marrow stem
cell mobilization and cardiac recovery [15]. In this report, we
demonstrated a strong association between plasma S1P levels and mobilized CPCs in a large cohort of patients with CAD,
a finding that is in agreement with our report in patients with
acute coronary syndrome [14]. Although the present data
do not prove a causal relationship between plasma S1P levels and CPC mobilization, combined with findings from our

previous mechanistic studies, the results support an important role
for S1P in modulating peripheral stem cell trafficking [13].

Clinical Implications
In conclusion, the bioactive lipid S1P strongly correlated with
CPC levels in patients with CAD in this study. Future studies
using adjunctive therapy with S1P to enhance bone marrow
mobilization of stem cells are needed to investigate its therapeutic benefit.
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Figure 1. Bar graphs depicting median circulating progenitor cell counts stratified by sphingosine-1-phosphate tertiles. Hematopoietic progenitor cell counts for subtypes CD341 (A), CD341/CD1331 (B), and CD341/CXCR41 (C). (D): Cell counts for the endothelial CD341/VEGFR21 subtype. Error bars represent 95% confidence interval. Nonparametric Kruskal-Wallis test p values are
given.
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